When the system narrows the legitimate path, demand doesn't disappear. It just moves somewhere nobody can track it.
The FDA restricted 19 peptides in September 2023. One month later, tirzepatide was approved for weight loss. A physician who has been using these compounds for 20 years explains what actually happened.
For patients with MCAS, POTS, and chronic inflammatory illness (patients who have nothing to do with weight loss) something else is happening. Dr. Hartman has been watching it for nearly 20 years.